Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126641) titled 'Based on the apoptotic and pyroptotic cell phenotypes, this study explores the mechanism of chronic high intraocular pressure-induced damage to optic ganglion cells and the intervention effect of Qingguan II Formula' on June 12.

Study Type: Observational study

Study Design: Factorial

Primary Sponsor: The First Hospital of Hunan University of Chinese Medicine

Condition: PrimaryOpen-AngleGlaucoma

Intervention: Primary Open-Angle Glaucoma (POAG) group:None

Recruitment Status: Recruiting

Phase: 0

Date of First Enrollment: 2025-09-05

Target Sample Size: Primary Open-Angle Glaucoma (POAG) group:60;Catarac...